Department of Nephrology and Rheumatology, Toranomon Hospital Kajigaya, Japan.
Department of Nephrology, Saga University Internal Medicine, Japan.
Intern Med. 2023 Jan 1;62(1):81-85. doi: 10.2169/internalmedicine.9059-21. Epub 2022 May 31.
A 43-year-old Japanese woman with rheumatoid arthritis treated by infliximab and methotrexate for 11 years was admitted for proteinuria and purpura. A kidney biopsy revealed endothelial damage-dominant nephritis with IgA deposition. Infliximab and methotrexate were discontinued, and tocilizumab was started; however, proteinuria persisted. Therefore, tocilizumab was discontinued, and oral prednisolone and methylprednisolone pulse therapy were administered. After 6 months, urinary protein was less than 0.1 g/day, and purpura subsided. To our knowledge, this is the first case of endothelial damage-dominant nephritis related to IgA vasculitis involving the skin and kidney after long-term use of infliximab and methotrexate.
一位 43 岁的日本女性,患有类风湿关节炎,使用英夫利昔单抗和甲氨蝶呤治疗 11 年,因蛋白尿和紫癜入院。肾脏活检显示内皮细胞损伤为主的肾炎伴 IgA 沉积。停用英夫利昔单抗和甲氨蝶呤,开始使用托珠单抗;然而,蛋白尿持续存在。因此,停用托珠单抗,并给予口服泼尼松龙和甲基泼尼松龙脉冲治疗。6 个月后,尿蛋白量少于 0.1g/天,紫癜消退。据我们所知,这是首例长期使用英夫利昔单抗和甲氨蝶呤后出现皮肤和肾脏 IgA 血管炎相关的内皮细胞损伤为主的肾炎的病例。